Braund, Rhiannon
Rhiannon Braund
VIAF ID: 1623149368788185980001 (Personal)
Permalink: http://viaf.org/viaf/1623149368788185980001
Preferred Forms
-
- 100 1 _ ‡a Braund, Rhiannon
- 100 1 _ ‡a Braund, Rhiannon
- 100 1 _ ‡a Braund, Rhiannon
- 100 1 _ ‡a Braund, Rhiannon
-
-
- 100 0 _ ‡a Rhiannon Braund
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Analysis of medications returned to community pharmacies | |
Are all pharmacy staff interested in potential future roles? | |
Beyond the four walls: an exploratory survey of location, employment and roles of pharmacists in primary health care. | |
Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital | |
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy | |
Degradation of pharmaceuticals in wastewater | |
Disposal practices for unused medications around the world | |
Distribution of fibroblast growth factor-2 (FGF-2) within model excisional wounds following topical application | |
District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes | |
Foreword | |
General practitioners' perceptions of pharmacists' new services in New Zealand | |
Green chemistry, green pharmacy, and life-cycle assessments | |
Hypromellose films for the delivery of growth factors for wound healing. | |
Identifying drug-related problems during transition between secondary and primary care in New Zealand | |
The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes. | |
Interventions performed by New Zealand community pharmacists while dispensing prescription medications | |
Introducing a checking technician allows pharmacists to spend more time on patient focused activities | |
Introduction | |
Investigating unused medications in New Zealand | |
The life-cycle of pharmaceuticals in the environment, 2016: | |
Management of short supply oral contraceptives | |
Medicines information in New Zealand: current services and future potential | |
New Zealand parent's perceptions of the use and safety of over the counter liquid analgesics. | |
Nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol for acute musculoskeletal injuries: physiotherapists' understanding of which is safer, more effective, and when to initiate treatment | |
Pharmacist-only trimethoprim: pharmacist satisfaction on their training and the impact on their practice | |
Pharmacist supply of sildenafil: pharmacists' experiences and perceptions on training and tools for supply. | |
Pharmacists' performance of clinical interventions during adherence support medication reviews | |
Prescribing practices | |
Preventing drug-related adverse events following hospital discharge: the role of the pharmacist. | |
Quality of electronic records documenting adverse drug reactions within a hospital setting: identification of discrepancies and information completeness | |
Recommending NSAIDs and paracetamol: A survey of New Zealand physiotherapists' knowledge and behaviours | |
Recruitment and retention of primary care patients into a research study investigating medication adherence | |
Renal medicine and clinical pharmacy | |
Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand. | |
The role of topical growth factors in chronic wounds | |
Summary and Conclusions | |
Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre | |
A systematic review and meta-analysis of pharmacist-led fee-for-services medication review | |
Using the Pharmaceutical Collection Database to identify patient adherence to oral hypoglycaemic medicines | |
UV-induced photodegradation of oseltamivir (Tamiflu) in water | |
ভূমিকা | |
মুখবন্ধ |